The reactive oxygen species- and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the α,β-unsaturated aldehyde 4-hydroacy-2-nonenal to 1,4-dihydroxy-2-nonene

被引:160
作者
Burczynski, ME [1 ]
Sridhar, GR [1 ]
Palackal, NT [1 ]
Penning, TM [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M006655200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human aldo-keto reductase AKR1C1 (20 alpha (3 alpha)-hydroxysteroid dehydrogenase) is induced by electrophilic Michael accepters and reactive oxygen species (ROS) via a presumptive antioxidant response element (Burczynski, M. E., Lin, H. K., and Penning, T. M. (1999) Cancer Res. 59, 607-614). Physiologically, AKR1C1 regulates progesterone action by converting the hormone into its inactive metabolite 20 alpha -hydroxyprogesterone, and toxicologically this enzyme activates polycyclic aromatic hydrocarbon trans-dihydrodiols to redox-cycling o-quinones, However, the significance of its potent induction by Michael accepters and oxidative stress is unknown. 4-Hydroxy-8-nonenal (HNE) and other alpha,beta -unsaturated aldehydes produced during lipid peroxidation were reduced by AKR1C1 with high catalytic efficiency. Kinetic studies revealed that AKR1C1 reduced HNE (K-m = 34 muM, k(cat) = 8.8 min(-1)) with a k(cat)/K-m similar to that for 20 alpha -hydroxysteroids. Six other homogeneous recombinant AKRs were examined for their ability to reduce HNE. Of these, AKR1C1 possessed one of the highest specific activities and was the only isoform induced by oxidative stress and by agents that deplete glutathione (ethacrynic acid). Several hydroxysteroid dehydrogenases of the AKR1C subfamily catalyzed the reduction of HNE with higher activity than aldehyde reductase (AKR1A1). NMR spectroscopy identified the product of the NADPH-dependent reduction of HNE as 1,4-dihydroxy-2-nonene. The K-m of recombinant AKR1C1 for nicotinamide cofactors (K-m NADPH similar to6 muM, K-m(app) NADH >6 mM) suggested that it is primed for reductive metabolism of HNE. Isoformspecific reverse transcription-polymerase chain reaction showed that exposure of HeppG2 cells to HNE resulted in elevated levels of AKR1C1 mRNA. Thus, HNE induces its own metabolism via AKR1C1, and this enzyme may play a hitherto unrecognized role in a response mounted to counter oxidative stress. AKRs represent alternative GSH-independent/NADPH-dependent routes for the reductive elimination of HNE. Of these, AKR1C1 provides an inducible cytosolic barrier to HNE following ROS exposure.
引用
收藏
页码:2890 / 2897
页数:8
相关论文
共 66 条
  • [21] JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117
  • [22] Engineering steroid 5β-reductase activity into rat liver 3α-hydroxysteroid dehydrogenase
    Jez, JM
    Penning, TM
    [J]. BIOCHEMISTRY, 1998, 37 (27) : 9695 - 9703
  • [23] Comparative anatomy of the aldo-keto reductase superfamily
    Jez, JM
    Bennett, MJ
    Schlegel, BP
    Lewis, M
    Penning, TM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 625 - 636
  • [24] A new nomenclature for the aldo-keto reductase superfamily
    Jez, JM
    Flynn, TG
    Penning, TM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (06) : 639 - 647
  • [25] Induction of metallothionein as an adaptive mechanism affecting the magnitude and progression of toxicological injury
    Klaassen, CD
    Liu, J
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 : 297 - 300
  • [26] Leatherbarrow R. J., 1987, ENZFITTER NONLINEAR
  • [27] Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation
    Lee, SH
    Rindgen, D
    Bible, RH
    Hajdu, E
    Blair, IA
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (07) : 565 - 574
  • [28] HEPATOCELLULAR METABOLISM OF 4-HYDROXY-2,3-NONENAL IS IMPAIRED IN CONDITIONS OF CHRONIC CHOLESTASIS
    LEONARDUZZI, G
    PAROLA, M
    MUZIO, G
    GARRAMONE, A
    MAGGIORA, M
    ROBINO, G
    POLI, G
    DIANZANI, MU
    CANUTO, RA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (02) : 669 - 675
  • [29] LI Y, 1993, J BIOL CHEM, V268, P21454
  • [30] Expression and characterization of recombinant type 2 3 alpha hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution
    Lin, HK
    Jez, JM
    Schlegel, BP
    Peehl, DM
    Pachter, JA
    Penning, TM
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (13) : 1971 - 1984